Leukemia Cell Differentiation
- 1 January 1999
- journal article
- review article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 32 (1), 143-154
- https://doi.org/10.1016/s0306-3623(98)00098-6
Abstract
No abstract availableKeywords
This publication has 141 references indexed in Scilit:
- Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathwaysLeukemia, 1997
- All‐trans retinoic acid and in vitro cytokine production by acute promyelocytic eukemia cellsEuropean Journal of Haematology, 1996
- Nitric oxide, a vital poison inside the immune and inflammatory networkResearch in Immunology, 1995
- A transcriptional co-repressor that interacts with nuclear hormone receptorsNature, 1995
- PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors.Proceedings of the National Academy of Sciences, 1994
- 1,25-Dihydroxyvitamin D3 Protects HL60 Cells against Apoptosis but Down-regulates the Expression of the bcl-2 GeneExperimental Cell Research, 1993
- Nitric Oxide-Releasing Agents Enhance Cytokine-Induced Tumor Necrosis Factor Synthesis in Human Mononuclear CellsBiochemical and Biophysical Research Communications, 1993
- Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signallingNature, 1992
- 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRαNature, 1992
- Nonspecific defence mechanism: the role of nitric oxideImmunology Today, 1991